Pamela Bean

Summary

Country: USA

Publications

  1. ncbi HIV: the road ahead
    Pamela Bean
    Rogers Memorial Hospital, Oconomowac, WI, USA
    Am Clin Lab 21:11-2. 2002
  2. ncbi New global initiatives to improve the interpretation of drug resistance testing for HIV-1
    Pamela Bean
    Am Clin Lab 21:22-4. 2002
  3. ncbi Use of contemporary biomarkers in the detection of chronic alcohol use
    Norman J Montalto
    Department of Family Medicine, West Virginia University School of Medicine, Charleston, WV, U.S.A
    Med Sci Monit 9:RA285-90. 2003
  4. ncbi Using the EDAC test to monitor abstinence and relapses during outpatient treatment
    James Harasymiw
    Alcohol Detention Services, West 236 S 7050 Big Bend Drive, Big Bend, WI 53103, USA
    J Addict Dis 24:101-13. 2005
  5. ncbi Gender differences in the progression of co-morbid psychopathology symptoms of eating disordered patients
    P Bean
    Eating Disorders Center, Rogers Memorial Hospital, Milwaukee, WI, USA
    Eat Weight Disord 10:168-74. 2005
  6. ncbi HIV genetic mutations causing resistance to the new drug T-20: recent findings
    Pamela Bean
    Am Clin Lab 21:15-6. 2002
  7. ncbi New drug targets for HIV
    Pamela Bean
    Rogers Memorial Hospital, Oconomowoc, WI 53066, USA
    Clin Infect Dis 41:S96-100. 2005
  8. ncbi A case study in hepatitis C disease progression: reaching out while searching for new clues
    Pamela Bean
    Am Clin Lab 21:20-1. 2002
  9. ncbi HDL, alcohol, and health: from the benefits of moderation to the hazards of abuse
    Pamela Bean
    Millennium Strategies, 418 N. Westfield Rd, Madison, WI 53717, USA
    Am Clin Lab 21:17-9. 2002
  10. ncbi A brief update on chemokines, chemokine receptors, and HIV
    Pamela Bean
    Am Clin Lab 21:14-6. 2002

Collaborators

Detail Information

Publications32

  1. ncbi HIV: the road ahead
    Pamela Bean
    Rogers Memorial Hospital, Oconomowac, WI, USA
    Am Clin Lab 21:11-2. 2002
  2. ncbi New global initiatives to improve the interpretation of drug resistance testing for HIV-1
    Pamela Bean
    Am Clin Lab 21:22-4. 2002
  3. ncbi Use of contemporary biomarkers in the detection of chronic alcohol use
    Norman J Montalto
    Department of Family Medicine, West Virginia University School of Medicine, Charleston, WV, U.S.A
    Med Sci Monit 9:RA285-90. 2003
    ..Improved awareness of alcohol misuse, increased use of screening tools, and the appropriate use of biochemical markers will facilitate early intervention and successful management of patients with alcohol use disorders...
  4. ncbi Using the EDAC test to monitor abstinence and relapses during outpatient treatment
    James Harasymiw
    Alcohol Detention Services, West 236 S 7050 Big Bend Drive, Big Bend, WI 53103, USA
    J Addict Dis 24:101-13. 2005
    ..The use of biomarkers to monitor drinking behavior in alcohol dependent patients is gaining popularity because they provide objective information on a patient's drinking status when used as an adjunct to self-report...
  5. ncbi Gender differences in the progression of co-morbid psychopathology symptoms of eating disordered patients
    P Bean
    Eating Disorders Center, Rogers Memorial Hospital, Milwaukee, WI, USA
    Eat Weight Disord 10:168-74. 2005
    ..A thorough clinical assessment of eating disordered patients including comorbid psychopathology disorders is relevant for clinical diagnosis, treatment planning, and perhaps ultimately the outcome of treatment...
  6. ncbi HIV genetic mutations causing resistance to the new drug T-20: recent findings
    Pamela Bean
    Am Clin Lab 21:15-6. 2002
  7. ncbi New drug targets for HIV
    Pamela Bean
    Rogers Memorial Hospital, Oconomowoc, WI 53066, USA
    Clin Infect Dis 41:S96-100. 2005
    ..New classes of anti-HIV drugs--and new drugs in existing classes--represent the best hope for people infected with HIV, especially those who have exhausted current therapies...
  8. ncbi A case study in hepatitis C disease progression: reaching out while searching for new clues
    Pamela Bean
    Am Clin Lab 21:20-1. 2002
  9. ncbi HDL, alcohol, and health: from the benefits of moderation to the hazards of abuse
    Pamela Bean
    Millennium Strategies, 418 N. Westfield Rd, Madison, WI 53717, USA
    Am Clin Lab 21:17-9. 2002
  10. ncbi A brief update on chemokines, chemokine receptors, and HIV
    Pamela Bean
    Am Clin Lab 21:14-6. 2002
  11. ncbi Containing the spread of HIV infection among high-risk groups
    Pamela Bean
    Millennium Strategies, 418 N. Westfield Rd, Madison, WI 53717, USA
    Am Clin Lab 21:19-21. 2002
  12. ncbi Current approaches to classic HIV paradigms
    Pamela Bean
    Rogers Memorial Hospital, Oconomowac, WI, USA
    Am Clin Lab 21:9-11. 2002
  13. ncbi The multiple benefits associated with HIV drug-resistance mutation M184V
    Pamela Bean
    Millennium Strategies, 418 N. Westfield Rd, Madison, WI 53717, USA
    Am Clin Lab 21:16-8. 2002
  14. ncbi New applications of contemporary biomarkers of alcohol consumption
    Pamela Bean
    Millennium Strategies, 418 N. Westfield Rd, Madison, WI 53717, USA
    Am Clin Lab 21:19-21. 2002
  15. ncbi Alcohol biomarkers as tools to guide and support decisions about intoxicated driver risk
    Pamela Bean
    Millennium Strategies, Madison, Wisconsin 53717, USA
    Traffic Inj Prev 10:519-27. 2009
    ..The pilot tested whether biomarkers (1) can help the assessor identify high-risk drivers who continue to drink heavily after their arrest and (2) detect relapses in drivers enrolled in their drivers' safety plans...
  16. ncbi New strategies in the treatment of hepatitis C
    Pamela Bean
    Millennium Strategies, 418 N. Westfield Rd, Madison, WI 53717, USA
    Am Clin Lab 21:18-20. 2002
  17. ncbi Evolving toxicities associated with anti-HIV therapies
    Pamela Bean
    Rogers Memorial Hospital, Oconomowac, WI, USA
    Am Clin Lab 21:12-5. 2002
  18. ncbi The use of alternative medicine in the treatment of hepatitis C
    Pamela Bean
    Rogers Memorial Hospital, Oconomowac, WI, USA
    Am Clin Lab 21:19-21. 2002
    ..Finally, some patients with hepatitis C take St. John's Wort and ginger to treat the side effects caused by interferon therapy. An excellent review of this subject was recently published by the NCCAM...
  19. ncbi Outcome variables for anorexic males and females one year after discharge from residential treatment
    Pamela Bean
    Rogers Memorial Hospital, 418 North Westfield Road, Madison, WI 53717, USA
    J Addict Dis 23:83-94. 2004
    ..This kind of study helps us evaluate treatment outcome and identify key variables that predict changes in anorexics' body weight over time...
  20. ncbi The reproducibility of the early detection of alcohol consumption test using split samples analyzed in different laboratories
    Pamela Bean
    Rogers Memorial Hospital, Madison, WI, USA
    Alcohol Alcohol 46:694-701. 2011
    ..It also describes the reproducibility of the EDAC over time by analyzing the results of testing one subject whose blood sample was sent to seven different laboratories over a 10-year period...
  21. ncbi The Early Detection of Alcohol Consumption (EDAC) test shows better performance than gamma-glutamyltransferase (GGT) to detect heavy drinking in a large population of males and females
    James Harasymiw
    Alcohol Detection Services, Big Bend, WI, USA
    Med Sci Monit 13:PI19-24. 2007
    ..Alcohol use was recorded by personal interview; heavy drinking was defined as males drinking 2.5 ounces of alcohol (5 drinks) per day and females drinking 2 ounces (4 drinks) of alcohol daily...
  22. ncbi Treatment issues and outcomes for males with eating disorders
    Theodore E Weltzin
    Department of Psychiatry, Medical College of Wisconsin, Milwaukee, and The Eating Disorder Center at Rogers Memorial Hospital, Oconomowoc, Wisconsin 53066, USA
    Eat Disord 20:444-59. 2012
    ..Data are presented which characterize psychiatric co-morbidity, excessive exercise, body image, sexuality, and spirituality in males. Treatment outcomes for males in this environment are positive...
  23. ncbi An interactive voice response program to reduce drinking relapse: a feasibility study
    James C Mundt
    Healthcare Technology Systems, Inc Madison, WI, USA
    J Subst Abuse Treat 30:21-9. 2006
    ..This pilot study suggests that using automated IVR technology to monitor clients after discharge is feasible and warrants further research and development. IVR systems also provide the potential for delivering individualized feedback...
  24. ncbi State of the art contemporary biomarkers of alcohol consumption
    Pamela Bean
    Rogers Memorial Hospital, Oconomowoc, WI, USA
    MLO Med Lab Obs 37:10-2, 14, 16-7; quiz 18-9. 2005
  25. ncbi Latest discoveries on the infection and coinfection with hepatitis D virus
    Pamela Bean
    Millennium Strategies, 418 N. Westfield Rd, Madison, WI 53717, USA
    Am Clin Lab 21:25-7. 2002
    ..These advances have enhanced the clinician's ability to accurately evaluate the stage of HDV infection, response to therapy, and occurrence of reinfection after orthotopic liver transplant...
  26. ncbi Role of HIV phenotypic assays in the management of HIV infection
    Gabrielle Heilek-Snyder
    ViroLogic, Inc, S. San Francisco, CA, USA
    Am Clin Lab 21:40-3. 2002
    ..In essence, phenotypic testing provides information to target antiretroviral therapy against the predominant HIV variant in the patient for a prolonged suppression of viral replication, decreased mortality, and lower health-care costs...
  27. ncbi Using routine laboratory tests to detect heavy drinking in the general population
    Jim Harasymiw
    Alcohol Detection Services, Big Bend, WI 53103, USA
    J Addict Dis 25:59-63. 2006
    ..The ultimate goal is to facilitate early intervention and the successful management of patients diagnosed with heavy drinking...
  28. ncbi Detection of alcohol misuse using a routine test panel: the early detection of alcohol consumption (EDAC) test
    Jim Harasymiw
    Alcohol Detection Services, W236 S7050 Big Bend Drive, Big Bend, WI 53103, USA
    Alcohol Alcohol 39:329-35. 2004
    ..This form of LDF aims to predict a categorical dependent variable (alcohol misuse) on the basis of several independent, predictor variables (routine laboratory tests)...
  29. ncbi The benefits of HIV resistance testing in optimizing drug discovery
    Gabrielle Heilek-Snyder
    Inflammatory and Viral Diseases Unit, Roche Biosciences, 3401 Hillview Ave, Palo Alto, CA 94304, USA
    Am Clin Lab 21:13-4. 2002
  30. ncbi An updated overview of the HCV infection process
    David Sainato
    American Association for Clinical Chemistry (AACC, 2101 L St, NW, Ste. 202, Washington, DC 20037-1526, USA
    Am Clin Lab 21:10-2. 2002
  31. ncbi The challenging interactions between antiretroviral agents and addiction drugs
    Jag Khalsa
    Center on AIDS and Other Medical Consequences of Drug Abuse (CAMCODA, National Institute on Drug Abuse, NIH, Rockville, MD, USA
    Am Clin Lab 21:10-3. 2002
  32. ncbi Basic principles underlying the emerging field of lipid therapy
    Pablo V Escriba
    Laboratory of Molecular and Cellular Biomedicine, Dept of Biology, University of the Balearic Islands, Ctra de Valldemossa km 7, 5, E 07071 Palma de Mallorca, Spain
    Am Clin Lab 21:29-31. 2002